NDAORALTABLET3 Generics Approved
Approved
Nov 1983
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
20
Data completeness
4/8 — Partial
FUROSEMIDE (furosemide) by Hikma. Approved for loop diuretic [epc]. First approved in 1983.
Drug data last refreshed 8h ago · AI intelligence enriched 10h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Furosemide is a generic loop diuretic oral tablet used to treat fluid overload conditions such as edema and hypertension. It works by inhibiting sodium and chloride reabsorption in the loop of Henle, promoting rapid diuresis. The drug has been a standard-of-care therapy for over 40 years across multiple therapeutic areas.
LOE Approaching
As an approaching LOE product in a mature market with 60% competitive pressure, brand team focus is on cost optimization and market defense rather than expansion.
Mechanism of Action
Pharmacologic Class:
Loop Diuretic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Bumetanide vs. Furosemide in Cirrhosis
Started Jun 2026
500 enrolled
Cirrhosis
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
Started Mar 2026
41 enrolled
Healthy
Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteers
Started Feb 2026
16 enrolled
Healthy
A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood
Started Aug 2024
32 enrolled
Healthy
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants
Started Jul 2024
91 enrolled
Healthy Participants
Worked on FUROSEMIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.